Gabelli Funds’s Checkpoint Therapeutics CKPT Stock Holding History

Gabelli Funds’s Portfolio CKPT Stock Details CKPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,105,950	Closed	-$4.47M	–	1228
2025 Q1	$4.47M	Buy	+1,105,950	New	+$3.69M	0.03%	493

Gabelli Funds's CKPT Position: Q2 2025 in Review

Gabelli Funds sold out of Checkpoint Therapeutics (CKPT) in Q2 2025, closing a stake of 1,105,950 shares — an estimated $4.47M sold.

Gabelli Funds first reported a position in CKPT in Q1 2025 and held it in 1 quarter. The position peaked at $4.47M in Q1 2025. 0 funds tracked by Wall St. Rank hold CKPT as of Q2 2025.

Gabelli Funds reported no remaining Checkpoint Therapeutics position as of Q2 2025 after selling out during the quarter.
Gabelli Funds sold 1,105,950 Checkpoint Therapeutics shares in Q2 2025, an estimated $4.47M.
Gabelli Funds first reported a position in Checkpoint Therapeutics in Q1 2025 and held it in 1 quarter.
Gabelli Funds's Checkpoint Therapeutics position peaked at $4.47M in Q1 2025.
0 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q2 2025.

Based on Gabelli Funds's 13F filing for Q2 2025, filed 13 Aug 2025.